Cancer drug linked to 39 Japan deaths
AstraZeneca PLC, Europe's second-largest drugmaker, has admitted that its new lung cancer-fighting drug sold under the Iressa brand was linked to 39 deaths in Japan.
AstraZeneca PLC, Europe's second-largest drugmaker, has admitted that its new lung cancer-fighting drug sold under the Iressa brand was linked to 39 deaths in Japan.